CHRM1 Receptor: A Potential Drug Target for Neurological Disorders

Target Name: CHRM1

NCBI ID: G1128

CHRM1

CHRM1 Receptor: A Potential Drug Target for Neurological Disorders

CHRM1 (Acetylcholine receptor, muscarinic 1) is a G protein-coupled receptor located on the postsynaptic side of a neuron. It is involved in various physiological processes including modulation of neurotransmitter release, pain perception, and neural circuits. The CHRM1 receptor has been identified as a potential drug target in the field of neurological disorders, including Alzheimer's disease, Parkinson's disease, and chronic pain. In this article, we will discuss the research on CHRM1 and its potential as a drug target.

History of CHRM1

The CHRM1 receptor was first identified in the 1970s as a muscarinic acetylcholine receptor. This receptor is composed of a extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain contains a N-terminus that is involved in the formation of a complex with a G protein. The transmembrane domain contains a protein transmembrane domain, which is responsible for the receptor's localization and interaction with other proteins. The intracellular domain contains a G protein-coupled receptor interface, which is responsible for the interaction with the G protein.

CHRM1 Receptor Interaction

The CHRM1 receptor is involved in various physiological processes, including modulation of neurotransmitter release, pain perception, and neural circuits. The CHRM1 receptor has been shown to play a role in the modulation of neurotransmitter release in the central nervous system (CNS). For example, studies have shown that the CHRM1 receptor is involved in the modulation of dopamine release in response to various neurotransmitters, including GABA and glutamate.

CHRM1 Receptor Involvement in Pain Perception

The CHRM1 receptor is also involved in the modulation of pain perception. Studies have shown that the CHRM1 receptor is involved in the modulation of pain sensitivity in response to various stimuli, including thermal, chemical, and mechanical stimuli. For example, studies have shown that activation of the CHRM1 receptor can increase pain sensitivity in response to thermal stimuli, while inhibition of the CHRM1 receptor can decrease pain sensitivity in response to thermal stimuli.

CHRM1 Receptor Role in Neural Circuits

The CHRM1 receptor is involved in various neural circuits, including the modulation of sensory input, motor output, and neural circuits. Studies have shown that the CHRM1 receptor is involved in the modulation of sensory input in the CNS, including the modulation of pain perception and neurotransmitter release. The CHRM1 receptor is also involved in the modulation of motor output, including the modulation of muscle contractions and neural circuits.

Potential Drug Targets

The CHRM1 receptor has been identified as a potential drug target in the field of neurological disorders, including Alzheimer's disease, Parkinson's disease, and chronic pain. The CHRM1 receptor is involved in various physiological processes, including modulation of neurotransmitter release, pain perception, and neural circuits, making it an attractive target for drug development.

Conclusion

In conclusion, the CHRM1 receptor is a G protein-coupled receptor that is involved in various physiological processes, including modulation of neurotransmitter release, pain perception, and neural circuits. The CHRM1 receptor has been identified as a potential drug target in the field of neurological disorders, including Alzheimer's disease, Parkinson's disease, and chronic pain. Further research is needed to fully understand the CHRM1 receptor and its potential as a drug target.

Protein Name: Cholinergic Receptor Muscarinic 1

Functions: The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover

The "CHRM1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CHRM1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets